Teladoc Health, Inc. (4LL.F)
EUR 6.2
(1.97%)
EUR 6.2
(1.97%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -248.55 Million USD | 98.18% |
| 2022 | -13.65 Billion USD | -5039.92% |
| 2021 | -265.63 Million USD | 47.55% |
| 2020 | -506.42 Million USD | -529.55% |
| 2019 | -80.44 Million USD | -13.53% |
| 2018 | -70.85 Million USD | 6.02% |
| 2017 | -75.39 Million USD | -20.31% |
| 2016 | -62.66 Million USD | -12.33% |
| 2015 | -55.78 Million USD | -268.22% |
| 2014 | -15.15 Million USD | -158.14% |
| 2013 | -5.86 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -87.12 Million USD | -148.35% |
| 2024 Q2 | -841.14 Million USD | -865.48% |
| 2023 Q1 | -77.1 Million USD | 97.98% |
| 2023 Q3 | -64.72 Million USD | 9.66% |
| 2023 Q2 | -71.64 Million USD | 7.08% |
| 2023 FY | -248.55 Million USD | 98.18% |
| 2023 Q4 | -35.08 Million USD | 45.8% |
| 2022 FY | -13.65 Billion USD | -5039.92% |
| 2022 Q4 | -3.81 Billion USD | -5219.33% |
| 2022 Q1 | -6.66 Billion USD | -15998.33% |
| 2022 Q2 | -3.09 Billion USD | 53.57% |
| 2022 Q3 | -71.73 Million USD | 97.68% |
| 2021 Q1 | -84.67 Million USD | 81.53% |
| 2021 Q4 | -41.42 Million USD | 31.61% |
| 2021 Q2 | -78.94 Million USD | 6.77% |
| 2021 Q3 | -60.57 Million USD | 23.27% |
| 2021 FY | -265.63 Million USD | 47.55% |
| 2020 Q3 | -19.72 Million USD | -174.76% |
| 2020 Q4 | -458.5 Million USD | -2224.49% |
| 2020 Q2 | -7.17 Million USD | 65.83% |
| 2020 FY | -506.42 Million USD | -529.55% |
| 2020 Q1 | -21.01 Million USD | -34.79% |
| 2019 Q1 | -22.88 Million USD | -28.31% |
| 2019 Q3 | -19.94 Million USD | 9.44% |
| 2019 Q4 | -15.58 Million USD | 21.84% |
| 2019 FY | -80.44 Million USD | -13.53% |
| 2019 Q2 | -22.02 Million USD | 3.78% |
| 2018 Q4 | -17.83 Million USD | -13.05% |
| 2018 FY | -70.85 Million USD | 6.02% |
| 2018 Q3 | -15.77 Million USD | 13.05% |
| 2018 Q2 | -18.14 Million USD | 4.95% |
| 2018 Q1 | -19.09 Million USD | 22.26% |
| 2017 Q3 | -21.54 Million USD | -48.64% |
| 2017 Q2 | -14.49 Million USD | 2.09% |
| 2017 Q4 | -24.55 Million USD | -14.01% |
| 2017 FY | -75.39 Million USD | -20.31% |
| 2017 Q1 | -14.8 Million USD | -11.88% |
| 2016 Q2 | -14.46 Million USD | 1.72% |
| 2016 Q4 | -13.23 Million USD | 34.69% |
| 2016 FY | -62.66 Million USD | -12.33% |
| 2016 Q3 | -20.25 Million USD | -40.07% |
| 2016 Q1 | -14.71 Million USD | -2.57% |
| 2015 FY | -55.78 Million USD | -268.22% |
| 2015 Q4 | -14.34 Million USD | -13.9% |
| 2015 Q3 | -12.59 Million USD | 22.5% |
| 2015 Q2 | -16.25 Million USD | -29.05% |
| 2015 Q1 | -12.59 Million USD | -101.58% |
| 2014 FY | -15.15 Million USD | -158.14% |
| 2014 Q2 | -2.85 Million USD | -30.62% |
| 2014 Q3 | -3.85 Million USD | -34.95% |
| 2014 Q4 | -6.24 Million USD | -61.97% |
| 2014 Q1 | -2.18 Million USD | 0.0% |
| 2013 FY | -5.86 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| DocCheck AG | 3.54 Million EUR | 7116.269% |
| CompuGroup Medical SE & Co. KGaA | 155.16 Million EUR | 260.19% |
| MeVis Medical Solutions AG | 6.44 Million EUR | 3957.265% |
| Nexus AG | 24.76 Million EUR | 1103.606% |